Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 5/2014

01.05.2014 | Neuromodulation (M Gofeld, Section Editor)

Peripheral Neuromodulation: A Review

verfasst von: Teodor Goroszeniuk, David Pang

Erschienen in: Current Pain and Headache Reports | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Peripheral nerve stimulation (PNS) is likely the most diverse and rapidly expanding area of neuromodulation. Its expansion has become possible due to both technological and clinical advances in pain medicine. The first implantable systems were surgically placed. However, it is currently commonplace to use percutaneous leads, as this approach has become instrumental in its expansion. The first percutaneous peripheral nerve stimulators were reported in 1999. Cylindrical leads were implanted to stimulate the greater occipital nerve to manage intractable headache. It has been expanded into other individual nerves or nerve plexuses to treat neuropathic, visceral, cardiac, abdominal, low back and facial pain. The use of PNS in modulating organ function in treatment of syndromes such as epilepsy, incontinence and obesity with vagal, tibial and gastric stimulation is under extensive investigation. New technologies that allow easier and safer electrode placement are expected to further expand the uses of PNS. A noninvasive stimulation will open this treatment modality to more clinicians of varying backgrounds.
Literatur
1.
Melzack R, Wall P. Pain mechanisms: a new theory. Science. 1965;150:971–8.PubMed
2.
Wall P, Sweet WH. Temporary abolition of pain in man. Science. 1967;155:108–9.PubMed
3.
Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation Technol Neural Interface. 1999;2:217–21.
4.
Linderoth B, Meyerson B. Spinal cord stimulation: exploration of the physiological basis of a widely used therapy. Anesthesiology. 2010;113(6):1265–7.PubMed
5.
Linderoth B. Spinal cord stimulation: a brief update on mechanism of action. Eur J Pain Supp. 2009;3:89–93.
6.
Ignelzi RJ, Nyquist JK. Direct effect of electrical stimulation on peripheral nerve evoked activity: Implications in pain relief. J Neurosurg. 1976;45:159–65.PubMed
7.
Sandkühler J, Chen JG, Cheng G, Randić M. Low-frequency stimulation of afferent Adelta-fibers induces long-term depression at primary afferent synapses with substantia gelatinosa neurons in the rat. J Neurosci. 1997;17(16):6483–91.PubMed
8.
Randić M, Jiang MC, Cerne R. Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. J Neurosci. 1993;13(12):5228–41.PubMed
9.
Hanai F. Effect of electrical stimulation of peripheral nerves on neuropathic pain. Spine (Phila Pa 1976). 2000;25(15):1886–92.
10.
Sluka KA, Deacon M, Stibal A, et al. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. J Pharmacol Exp Ther. 1999;289:840–6.PubMed
11.
Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther. 2001;298:257–63.PubMed
12.
Radhakrishnan R, Sluka KA. Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats. Neuropharmacology. 2003;45:1111–9.PubMedCentralPubMed
13.
Radhakrishnan R, King EW, Dickman J, et al. Blockade of spinal 5-HT receptor subtypes prevents low, but not high, frequency TENS-induced antihyperalgesia in rats. Pain. 2003;105:205–13.PubMedCentralPubMed
14.
Maeda Y, Lisi TL, Vance CG, Sluka KA. Release of GABA and activation of GABAA receptors in the spinal cord mediates the effects of TENS in rats. Brain Res. 2007;1136:43–50.PubMedCentralPubMed
15.
Sluka KA, Lisi TL, Westlund KN. Increased release of serotonin in the spinal cord during low, but not high, frequency transcutaneous electric nerve stimulation in rats with joint inflammation. Arch Phys Med Rehabil. 2006;87:1137–40.PubMedCentralPubMed
16.
Chandran P, Sluka KA. Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration. Pain. 2003;102:195–2011.PubMed
17.
Han JS, Chen XH, Sun SL, et al. Effect of low and high frequency TENS on met-enkephalin-arg-phe and dynorphin A immunoreactivity in human lumbar CSF. Pain. 1991;47:295–8.PubMed
18.
Salar G, Job I, Mingrino S, et al. Effect of transcutaneous electrotherapy on CSF β-endorphin content in patients without pain problems. Pain. 1981;10:169–72.PubMed
19.••
Vera-Portocarrero LP, Cordero T, Billstrom T, et al. Differential Effects of Subcutaneous Electrical Stimulation (SQS) and Transcutaneous Electrical Nerve Stimulation (TENS) in Rodent Models of Chronic Neuropathic or Inflammatory Pain. Neuromodulation. 2013;16:328–35. This important study demonstrates that the mechanism of action in peripheral nerve stimulation with subcutaneous leads differs from and may be more effective than TENS.PubMed
20.
Ellrich J, Lamp S. Peripheral nerve stimulation inhibits nociceptive processing: an electrophysiological study in healthy volunteers. Neuromodulation. 2005;8(4):225–32.PubMed
21.
Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127:220–30.PubMed
22.
Busch V, Jakob W, Juergens T, et al. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia. 2006;26:50–5.PubMed
23.
Mueller O, Hagel V, Wrede K, et al. Stimulation of the greater occipital nerve: anatomical considerations and clinical implications. Pain Phys. 2013;16(3):E181–9.
24.••
Saper JR, Dodick DW, Silberstein SD, et al. ONSTIM Investigators. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271–85. This is the first published randomised study on the use of occipital stimulation in migraine.PubMedCentralPubMed
25.
Lipton RB, Goadsby PJ, Cady RK, et al. PRISM study: occipital nerve stimulation for treatment-refractory migraine [abstract PO47]. Cephalalgia. 2009;29(1 Suppl 1):30.
26.
Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomised, multicenter, double blinded, control study. Cephalalgia. 2012;32(16):1165–79.PubMed
27.
May A, Bahra A, Büchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–8.PubMed
28.
Leone M, Franzini A, Cecchini AP, et al. Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord. 2010;3:187–95.PubMedCentralPubMed
29.
Leone M, Franzini A, Cecchini AP, et al. Deep brain stimulation in trigeminal autonomic cephalalgias. Neurotherapeutics. 2010;7:220–8.PubMed
30.
Magis D, Bruno MA, Fumal A, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11:25.PubMedCentralPubMed
31.
Magis D, Allena M, Bolla M, et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol. 2007;6(4):314–21.PubMed
32.
Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007;369:1099–106.PubMed
33.
Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache – long-term safety and efficacy. Cephalalgia. 2007;27:153–7.PubMed
34.
Wilbrink LA, Teernstra OP, Haan J, et al. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia. 2013;33(15):1238–47.
35.
Narouze S, Kapural L, Casanova J, et al. Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache. 2009;49:571–7.PubMed
36.
Ansarinia M, Rezai A, Tepper S, et al. Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches. Headache. 2010;50:1164–74.PubMed
37.
Seylaz J, Hara H, Pinard E, et al. Effect of stimulation of the sphenopalatine ganglion on cortical blood flow in the rat. J Cereb Blood Flow Metab. 1988;8:875–8.PubMed
38.
Schoenen J, Jensen RH, Lanteri-Minet M, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33(10):816–30.PubMedCentralPubMed
39.
Young RF. Electrical stimulation of the trigeminal nerve root for the treatment of chronic facial pain. J Neurosurg. 1995;83(1):72–8.PubMed
40.
Holsheimer J. Electrical stimulation of the trigeminal tract in chronic, intractable facial neuralgia. Arch Physiol Biochem. 2001;109(4):304–8.PubMed
41.
Taub E, Munz M, Tasker RR. Chronic electrical stimulation of the gasserian ganglion for the relief of pain in a series of 34 patients. J Neurosurg. 1997;86(2):197–202.PubMed
42.
Slavin KV, Colpan ME, Munawar N, et al. Trigeminal and occipital peripheral nerve stimulation for craniofacial pain: a single-institution experience and review of the literature. Neurosurg Focus. 2006;21(6):E5.PubMed
43.
Goroszeniuk T, Kothari S, Hamann W. Subcutaneous neuromodulating implant targeted at the site of pain. Reg Anesth Pain Med. 2006;31(2):168–71.PubMed
44.
Kent M, Upp J, Spevak C, et al. Ultrasound-guided peripheral nerve stimulator placement in two soldiers with acute battlefield neuropathic pain. Anesth Analg. 2012;114(4):875–8.PubMed
45.
Narouze SN, Zakari A, Vydyanathan A. Ultrasound-guided placement of a permanent percutaneous femoral nerve stimulator leads for the treatment of intractable femoral neuropathy. Pain Phys. 2009;12(4):E305–8.
46.
Huntoon MA, Burgher AH. Ultrasound-guided permanent implantation of peripheral nerve stimulation (PNS) system for neuropathic pain of the extremities: original cases and outcomes. Pain Med. 2009;10(8):1369–77.PubMed
47.
Dunteman E. Peripheral nerve stimulation for unremitting ophthalmic post-herpetic neuralgia. Neuromodulation. 2002;5(1):32–7.PubMed
48.
Stinson LW, Roderer GT, Cross NE, David BE. Peripheral subcutaneous neurostiomulation for Control of Intractable Post-operative inguinal pain: a case report series. Neuromodulation. 2001;4(3):99–104.PubMed
49.
Kothari S, Goroszeniuk T. Percutaneous permanent electrode implantation to ulnar nerves for upper extremity chronic pain: 6 year follow up. Reg Anesth Pain Med. 2006;31(5 Supp):16.
50.
Siddalingaiah V, Goroszeniuk T, Palmisani S, et al. Permanent percutaneous sciatic nerve stimulation for treatment of severe neuropathic Pain. [Abstract PH 367] Presented at the Proceedings of the 13th World Congress on Pain, Montreal, Canada, 29 August–2 September 2010.
51.
Shetty A, Pang D, Mendis V, et al. Median nerve stimulation in forearm for treatment of neuropathic pain post re-implantation of fingers: A case report. Pain Practice. 2012;12(1 Supp):92.
52.
Bouche B, Eisenberg E, Meignier M, et al. Facilitation of diagnostic and percutaneous trial lead placement with ultrasound guidance for peripheral nerve stimulation ilioinguinal neuralgia. Abstracts from the 10th World Congress of the International Neuromodulation Society. Neuromodulation. 2011;14:563.
53.
Kemler MA, Barendse GA, van Kleef M, de Vet HC, Rijks CP, Furnee CA, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000;343:618–24.PubMed
54.
Goroszeniuk T, Kothari SC, Hamann WC. Percutaneous implantation of a brachial plexus electrode for management of pain syndrome caused by a traction injury. Neuromodulation. 2007;10:148–55.PubMed
55.
Goroszeniuk T, Pang D, Krol A, Kothari S. A novel technique of percutaneous brachial plexus stimulation for chronic neuropathic pain. Eur J Pain Supp. 2011;5:95.
56.
Petrovic Z, Goroszeniuk T, Kothari S. Percutaneous lumbar plexus Stimulation in the treatment of intractable pain. Reg Anesth Pain Med. 2007;32(5 Supp 1):11.
57.
Hegharty D, Goroszeniuk T. Peripheral nerve stimulation of the thoracic paravertebral plexus for chronic neuropathic pain. Pain Physician. 2011;14(3):295–300.
58.
Goroszeniuk T. Short neuromodulation trial in neuropathic pain produces varying duration but reproducible pain relief. [Abstract 494 T]. Presented at Pain in Europe IV Congress of EFIC, Prague, Czech Republic, 2–6 September 2003.
59.
Goroszeniuk T, Kothari S. Subcutaneous targeted stimulation. In: Krames ES, Peckham PH, Rezai AR, Elsevier BV, editors. Textbook of neuromodulation. San Diego: Academic Press; 2009. p. 417–27.
60.
O’Keeffe JD, O’Donnell BD, Tan T, Roets M. Subcutaneous electrical nerve stimulation (SENS one shot) in the treatment of neuropathic pain. Proceeding of the 9th Meeting of the NANS. Neuromodulation. 2006;9(1):8–20.
61.
Abejón D, Krames ES. Peripheral nerve stimulation or is it peripheral subcutaneous field stimulation; what is in a moniker? Neuromodulation. 2009;12(1):1–4.PubMed
62.
Levy RM. Differentiating the leaves from the branches in the tree of neuromodulation: the state of peripheral nerve field stimulation. Neuromodulation. 2011;14:201–5.PubMed
63.
Paicius RM, Bernstein CA, Lempert-Cohen C. Peripheral nerve field stimulation in chronic abdominal pain. Pain Physician. 2006;9:261–6.PubMed
64.
Burgher AH, Huntoon MA, Turley TW, et al. Subcutaneous peripheral nerve stimulation with inter-lead stimulation for axial neck and low back pain: case series and review of the literature. Neuromodulation. 2012;15(2):100–6.PubMed
65.
Goroszeniuk T, Kothari S, Ready R, et al. Sacroiliac joint chronic pain managament: targeted neuromodulation implantation, a novel approach. Reg Anesth Pain Med. 2008;33(5):221.
66.
Paicius RM, Bernstein CA, Lempert-Cohen C. Peripheral nerve field stimulation for the treatment of chronic low back pain: preliminary results of long-term follow-up: a case series. Neuromodulation. 2007;10(3):279–90.PubMed
67.
McRoberts WP, Roche M. Novel approach for peripheral subcutaneous field stimulation for the treatment of severe, chronic knee joint pain after total knee arthroplasty. Neuromodulation. 2010;13:131–6.PubMed
68.
Theodosiadis P, Samoladas E, Grosomanidis V, et al. A case of successful treatment of neuropathic pain after a scapular fracture with subcutaneous targeted neuromodulation. Neuromodulation. 2008;11(1):62–5.PubMed
69.••
Sator-Katzenschlager S, Fiala K, Kress HG, et al. Subcutaneous Target Stimulation (STS) in chronic noncancer pain: a nationwide retrospective study. Pain Pract. 2010;10:279–86. This important study is the first large case series on the successful use of peripheral subcutaneous stimulation for low back pain.PubMed
70.
Verrills P, Vivian D, Mitchell B, Barnard A. Peripheral nerve field stimulation for chronic pain: 100 cases and review of the literature. Pain Med. 2011;12:1395–405.PubMed
71.
Abejón D, Deer T, Verrills P. Subcutaneous stimulation: how to assess optimal implantation depth. Neuromodulation. 2011;14:343–8.PubMed
72.
Ekre O, Eliasson T, Norrsell H, Warhrborg P, Mannheimer C. Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study. Eur Heart J. 2002;23:1938–45.PubMed
73.•
Goroszeniuk T, Pang D, Al-Kaisy A, Sanderson K. Subcutaneous target stimulation–peripheral subcutaneous field stimulation in the treatment of refractory angina: preliminary case reports. Pain Pract. 2012;12:71–9. This describes the use of subcutaneous stimulation in refractory angina in patients with previous spinal cord stimulation failure.PubMed
74.
Buiten MS, DeJongste MJL, Beese U, et al. Subcutaneous electrical nerve stimulation: a feasible and new method for the treatment of patients with refractory angina. Neuromodulation. 2011;14:258–65.PubMed
75.
76.
Goroszeniuk T, Khan R, Kothari S. Lumbar sympathetic chain neuromodulation with implanted electrodes for long term pain relief in loin pain Haematuria Syndrome. Neuromodulation. 2009;12(4):284–91.PubMed
77.•
Goroszeniuk T, Khan R. Permanent percutaneous splanchnic nerve neuromodulation for management of pain due to chronic pancreatitis—a case report. Neuromodulation. 2011;14(3):253–7. This is the first description of implanted leads in the treatment of pancreatic pain at the splanchnic nerves.PubMed
78.•
Mironer YE, Hutcheson JK, Satterthwaite JR, LaTourette PC. Prospective, two-part study of the interaction between spinal cord stimulation and peripheral nerve field stimulation in patients with low back pain: development of a new spinal-peripheral neurostimulation method. Neuromodulation Technol Neural Interface. 2011;14(2):151–4. This study shows that SCS and PNS may be combined and that they are not mutually exclusive.
79.
Navarro RM, Vercimak DC. Triangular stimulation method utilizing combination spinal cord stimulation with peripheral subcutaneous field stimulation for chronic pain patients: a retrospective study. Neuromodulation. 2012;15:124–31.PubMed
80.
Shetty A, Pang D, Azzopardi J, Goroszeniuk T. Long term follow up of combined coeliac plexus and spinal cord stimulatior implant for pain duet o chronic pancreatitis: a novel approach. Reg Anesth Pain Med. 2012;37(Supp 1, 5):E198.
81.
Hamm-Faber TE, Aukes HA, de Loos F, Gültuna I. Subcutaneous stimulation as an additional therapy to spinal cord stimulation for the treatment of lower limb pain and/or back pain: a feasibility study. Neuromodulation. 2012;15(2):108–16.PubMed
82.
Connor Jr DE, Nixon M, Nanda A, Guthikonda B. Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature. Neurosurg Focus. 2012;32(3):E12.PubMed
83.
84.
Zabara J. Peripheral control of hypersynchronous discharge in epilepsy. Electroencephalography. 1985;61:S162.
85.
Müller K, Fabó D, Entz L, Kelemen A, Halász P, Rásonyi G, et al. Outcome of Vagus nerve stimulation for epilepsy in Budapest. Epilepsia. 2010;51(Suppl S3):98–101.PubMed
86.
Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy, and predictors of response. J Neurosurg. 2011;115:1248–55.PubMed
87.
Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation for treatment resistant depressions: a multicenter study. Biol Psychiatry. 2000;47:276–86.PubMed
88.
Bajbouj M, Merkl A, Schlaepfer TE, et al. Two-year outcome of Vagus nerve stimulation in treatment-resistant depression. Clin Psychopharmacol. 2010;30:273–81.
89.
Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in Adult rat Hippocampus. J Neurosci. 2000;20:9104–10.PubMed
90.
Bodenlos JS, Kose S, Borckardt JJ, et al. Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite. 2007;48:145–53.PubMed
91.
Nesbitt A, Marin J, Tomkins E, Ruttledge M, Goadsby P. Non-invasive vagus nerve stimulation for the treatment of cluster headache: A cohort series with extended follow-up. [Abstract .12 June – 025] Presented at the 11th International Neuromodulation Society World Congress, Berlin, Germany, 10-13 June 2013.
92.
Rutkowski B, Niedzialkowska T, Otto J. Electrical stimulation in chronic low-back pain. Br J Anaesth. 1977;49(6):629–32.PubMed
93.
Rutkowski B, Niedzialkowska T, Otto J. Electrostimulation in the management of chronic pain. Anaesthetist. 1975;24(10):457–60.
94.
Ghoname EA, White PF, Ahmed HE, et al. Percutaneous electrical nerve stimulation: an alternative to TENS in the management of sciatica. Pain. 1999;83(2):193–9.PubMed
95.
Hamza MA, White PF, Craig WF, Ghoname ES, Ahmed HE, Proctor TJ, et al. Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diabetes Care. 2000;23:365–70.PubMed
96.
Raphael J, Raheem T, Southall J, Bennett A, Ashford R, Williams S. Randomized double-blind sham-controlled crossover study of short-term effect of percutaneous electrical nerve stimulation in neuropathic pain. Pain Med. 2011;12(10):1515–22.PubMed
97.
Ghoname EA, Craig WF, White PF, Ahmed HE, Hamza MA, Henderson BN, et al. Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study. JAMA J Am Med Assoc. 1999;281:818–23.
98.
Goroszeniuk T. Percutaneous insertion of permanent peripheral stimulating electrode in patients with neuropathic pain [Abstract 59]. Presented at the 6th International Neuromodulation Society World Congress; 2003 June 25–26; Madrid, Spain.
99.
Goroszeniuk T, Kothari S. Targeted external area stimulation. Reg Anesth Pain Med. 2004;29(4 Suppl 5):98.
100.
Kothari S, Goroszeniuk T. External neuromodulation as a diagnostic and therapeutic procedure. Eur J Pain. 2006;10 Suppl 1:S158.
101.
Goroszeniuk T, Pratap N, Kothari S, Sanderson K. An algorithm for peripheral neuromodulation in neuropathic pain. [Abstract 4, December 9] . Presented at the 8th World Congress of International Neuromodulation Society and 11th Annual Meeting of North American Neuromodulation Society. 9–12 December 2007, Acapulco, Mexico.
102.
Shetty A, Goroszeniuk T, Pang D, et al. A novel stimulating probe for external neuromodulation in body cavities. [Abstract 043 June 11]. Presented at the 11th International Neuromodulation Society World Congress, Berlin, Germany, 10-13 June 2013.
103.
Biemans JM, van Balken MR. Efficacy and effectiveness of percutaneous tibial nerve stimulation in the treatment of pelvic organ disorders: a systematic review. Neuromodulation. 2013;16(1):25–33. discussion 33.PubMed
104.
Moossdorff-Steinhauser HF, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review. Neurourol Urodyn. 2013;32(3):206–14.PubMed
105.
Peters KM, Carrico DJ, Wooldridge LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194–201.PubMed
106.
Nashold BS, Goldner JL, Mullen JB, Bright DS. Long-term pain control by direct peripheral nerve stimulation. J Bone Joint Surg Am. 1982;64:1–10.PubMed
107.
Picaza JA, Hunter SE, Cannon BW. Pain suppression by peripheral nerve stimulation. Appl Neurophysiol. 1977;40:223–34.PubMed
108.
Waisbrod G, Panhans C, Hansen D, Gerbershagen HU. Direct nerve stimulation for painful peripiheral neuropathies. J Bone Joint Surg Am. 1985;67-B:470–2.
109.
Nielson KD, Watts C, Clark WK. Peripheral nerve injury from implantation of chronic stimulating electrodes for pain control. Surg Neurol. 1976;5:51–3.PubMed
110.
Goroszeniuk T, Pang D, Shetty A, et al. Peripheral nerve and subcutaneous targeted stimulation using a stimulating coude needle. Neuromodulation. 2014. doi:10.​1111/​ner.​12126.
111.
Shellock F G, Audet-Griffin A J. Evaluation of magnetic resonance imaging issues for a wirelessly powered lead used for epidural, spinal cord stimulation. Neuromodulation Technol Neural Interface. 5th Aug 2013. doi:10.​1111/​ner.​12094.
112.
Soin A, Fang ZP, Shah NS. Pilot Study on High-Frequency Nerve Block for Amputation Pain: Initial Results. [Abstract 010 June 11]. Presented at the 11th International Neuromodulation Society World Congress, Berlin, Germany, 10–13 June 2013.
113.
Aló KM, Abramova MV, Richter EO. Percutaneous peripheral nerve stimulation. Prog Neurol Surg. 2011;24:41–57.PubMed
114.
Rasskazoff SY, Slavin KV. An update on peripheral nerve stimulation. J Neurosurg Sci. 2012;56(4):279–85.PubMed
115.
Stanton-Hicks M, Panourias IG, Sakas DE, Slavin KV. The future of peripheral nerve stimulation. Prog Neurol Surg. 2011;24:210–7.PubMed
Metadaten
Titel
Peripheral Neuromodulation: A Review
verfasst von
Teodor Goroszeniuk
David Pang
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 5/2014
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-014-0412-9

Weitere Artikel der Ausgabe 5/2014

Current Pain and Headache Reports 5/2014 Zur Ausgabe

Imaging (A DaSilva, Section Editor)

Migraine and Reward System—Or Is It Aversive?

Trigeminal Autonomic Cephalalgias (M Matharu, Section Editor)

Structural Imaging in Cluster Headache

Uncommon Headache Syndromes (J Ailani, Section Editor)

Reversible Cerebral Vasoconstriction Syndrome: Updates and New Perspectives

Childhood and Adolescent Headache (S Evers, Section Editor)

Headache and Obesity in the Pediatric Population

Trigeminal Autonomic Cephalalgias (M Matharu, Section Editor)

Role of Angiotensin Modulation in Primary Headaches

Uncommon Headache Syndromes (J Ailani, Section Editor)

Occipital Neuralgia

Neu im Fachgebiet AINS

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise